G-Therapeutics announces today that it has raised EUR 36 million to develop its novel neuro-stimulation therapy for people with spinal cord injuries (SCI). G-Therapeutics is a spin-off from EPFL. The clinical and regulatory activities of the Company will remain in Lausanne. The general management of the Company will be based at Eindhoven, the Netherlands.
G-Therapeutics raises EUR 36 million
Posted on 19.04.2016 in News